SM
VINC
Sabby Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-57,353
| Closed | -$57.9K | – | 77 |
|
|
2023
Q3 | $57.9K | Sell |
57,353
-45,747
| -44% | -$46.2K | 0.04% | 49 |
|
|
2023
Q2 | $134K | Sell |
103,100
-250,300
| -71% | -$325K | 0.11% | 46 |
|
|
2023
Q1 | $368K | Sell |
353,400
-146,600
| -29% | -$152K | 0.32% | 25 |
|
|
2022
Q4 | $510K | Sell |
500,000
-5,559
| -1% | -$5.67K | 0.45% | 21 |
|
|
2022
Q3 | $698K | Buy |
505,559
+5,000
| +1% | +$6.9K | 0.88% | 20 |
|
|
2022
Q2 | $661K | Buy |
500,559
+173,323
| +53% | +$229K | 0.45% | 23 |
|
|
2022
Q1 | $1.31M | Buy |
327,236
+68,347
| +26% | +$273K | 0.2% | 20 |
|
|
2021
Q4 | $2.64M | Buy |
258,889
+58,889
| +29% | +$600K | 0.38% | 24 |
|
|
2021
Q3 | $3.23M | Sell |
200,000
-71,063
| -26% | -$1.15M | 0.44% | 15 |
|
|
2021
Q2 | $3.52M | Buy |
271,063
+188,115
| +227% | +$2.44M | 0.5% | 12 |
|
|
2021
Q1 | $1.6M | Buy |
+82,948
| New | +$1.6M | 0.31% | 29 |
|